Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

ConditionModerate to Severe Atopic Dermatitis

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age18-75

SponsorJiangsu vcare pharmaceutical technology co., LTD

About this trial

This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

VC005 low dose group
VC005 high dose group
VC005 Placebo group

Treatment groups

480 Participants

are divided into 3 treatment groups

Sponsors and collaborators

Jiangsu vcare pharmaceutical technology co., LTD